SlideShare a Scribd company logo
Flow-regulated vs Pressure-regulated shunts: A Prospective Analysis in Patients with Idiopathic Normal
Pressure Hydrocephalus
Phillip G. St. Louis MD; Jennifer Clements
Associates in Neurosurgery
Introduction
Guidelines for treatment of
Idiopathic Normal Pressure
(INPH)indicate ventriculoperitoneal
shunt placement as an effective
intervention. Current literature
comparing Differential Pressure
(DP) versus Flow Regulated (FR)
Valves for is lacking. This
prospective study evaluates one
year outcome data of 43 patients
randomized to either a DP or FR
valve.
Methods
All patients completed pre-operative
and post-operative evaluations to
assess hallmark indicators of INPH
such as magnetic gait (BERG
Balance Scale), cognitive
dysfunction (Neuropsychological
Assessment Battery [NAB]), and
ventriculomegaly (MRI/CT).
Patients who consented were then
randomized to a DP or FR valve.
Results
Baseline testing of the DP Group
(N=22) was NAB: 78.16 and BERG
34.2. Significant improvement was
demonstrated at 6 and 12 months
post-operatively with NAB: 86.5 and
87.75, and BERG 43.06,44.17
scores.
Baseline testing for the FR Group
(N=21) was NAB: 77.4 and BERG:
39. Improvement was noted at 6
and 12 months post operatively with
NAB: 86.25 and 89.17. There was a
slight decrease in the 6 and 12
month BERG: 47.2 and 46.11
scores. There were no shunt
infections. There was one subdural
hematoma in the FR Group requiring
surgical intervention in the
immediate post-operative period,
and 3 subdural hematomas in the
DP Group requiring 1 surgical
intervention. The number of follow
up appointments was slightly
increased in the DP Group, which
was primarily related to patients who
required shunt reprogramming.
Conclusions
Both shunt systems appear to be
effective in treatment of INPH.
Improvement was noted in both NAB
and BERG at 6 and 12 months post-
operatively when compared to
baseline. There was a distinct trend
of more striking improvement at 6
months in the FR Group. A
significantly higher incidence of
subdural hematomas was
demonstrated in the DP Group, most
of which were successfully managed
by shunt reprogramming.
Learning Objectives
Patients with Flow Regulated Valves
demonstrated a more striking
improvement at 6 months. Patients
with Differential Pressure Valves
experienced a larger incidence of
subdural hematomas, however most
of which were managed by shunt
reprogramming. Both groups
demonstrated overall improvement
when compared to baseline
References
1.Gangemi M, Maiuri F, Naddeo M, Godano U,
Mascari C, Broggi, et al: Endoscopic Third
Ventriculostomy in Idiopathic Normal Pressure
Hydrocephalus: An Italian Multicenter Study.
Neurosurg, 63: 62-69, 2008.
2.Hanlow P, Cinalli G, Vandertop P, Faber J,
Bogeskov L, Borgesen S, et al: Treatment of
hydrocephalus determined by the European
Orbis Sigma Valve II survey: a multicenter
prospective 5-year shunt survival study in
children and adults whom a flow-regulating
shunt was used. J Neurosurg 99: 52-57,
2003.3.Philippe D, Barat J, Duplessis E,
Leguerinel C, Gendrault P, and Keravel Y: Shunt
failure in adult hydrocephalus: Flow-controlled
shunt versus differential pressure shunts- A
cooperative study in 289 patients. Surg Neurol
43:333-339, 1995.4.Weiner H, Shlomo C,
Cohen H, Wisoff J: Current Treatment of Normal
-pressure Hydrocephalus: Comparison of Flow-
regulated and Differential-pressure Shunt
Valves. Neurosurg, 37(5):877-884,
1995.5.Zemack G, and Romner B: Adjustable
Valves in normal-pressure hydrocephalus: A
retrospective study of 218 patients. Neurosurg
51:1392-1402, 2002.6.Knutsson E, Lying-Tunell
U. Gait apraxia in normal-pressure
hydrocephalus: Patterns of movement and
muscle activation. Neurology 35, 135-
160.7.Bugalho P, Guimaraes J. Gait disturbance
in normal pressure hydrocephalus: A clinical
study. Parkinsonism and Related Disorders 13,
434-437, 2007.8.St Louis P, Horn G, Gorman P,
Johnson-Markve B, Wong B, Brustch B, Baez-
Torres S, Cole A, Tuppeny M, Johnson R.
Neurotransmission. 4, 1 2012. 9.Ravdin et al.
Features most responsive to tap test in normal
pressure hydrocephalus. Clin Neurol
Neurosurg.2008 May; 110 (5): 455-461.10.
Shprecher D, Schwalb J, Kurlan R. Normal
Pressure Hydrocephalus: Diagnosis and
Treatment. Curr Neurol Neurosci Rep. 2008
September; 8(5): 371-376.11.Merten T.
Neuropsychology of Normal Pressure
Hydrocephalus [in German]. Nervenarzt 70:496
-503, 1999. 12. Relkin N, Marmarou A, Klinge
P, Bergsneider M, Black P. Diagnosing
Idiopathic Normal-Pressure Hydrocephalus.
Neurosurgery. 57:3, 2005. 13. Vaneste JA.
Diagnosis and management of normal pressure
hydrocephalus. J Neurol. 2000;247:5-14. 14.
Donoghue D; Physiotherapy Research and Older
People (PROP) group, Stokes EK. (2009). How
much change is true change? The minimum
detectable change of the Berg Balance Scale in
elderly people. J Rehabil Med. 41(5):343-6. 15
Stern, R. A. & White T. (2003).
Neuropsychological Assessment Battery:
Administration, Scoring, and Interpretation
Manual,Psychological Assessment Resources,
Inc., Lutz, FL.16.Duff K. Evidence-based
indicators of neuropsychological change in the
individual patient: Relevant concepts and
methods; Kevin Duff; archives of clinical
neuropsychology; May 2012; 27(3): 248-261.
BERG Balance Scale
NAB
BERG Balance Scale
NAB

More Related Content

What's hot

Reduce the hospitalization
Reduce the hospitalizationReduce the hospitalization
Reduce the hospitalizationAnna Wu
 
Journal club 20 10-2016
Journal club 20 10-2016Journal club 20 10-2016
Journal club 20 10-2016
Amit Verma
 
Obstructive lung disease
Obstructive lung diseaseObstructive lung disease
Obstructive lung disease
Kristopher Maday
 
Goal directed resuscitation for patients
Goal directed resuscitation for patientsGoal directed resuscitation for patients
Goal directed resuscitation for patients
DrJawad Butt
 
Dizziness
DizzinessDizziness
Dizziness
pharmacy29
 
Evidence Based Approach to PTE
Evidence Based Approach to PTEEvidence Based Approach to PTE
Evidence Based Approach to PTE
Kristopher Maday
 
Anticoagulation in pediatric ventricular assist device - WCPCCS 2017
Anticoagulation in pediatric ventricular assist device - WCPCCS 2017Anticoagulation in pediatric ventricular assist device - WCPCCS 2017
Anticoagulation in pediatric ventricular assist device - WCPCCS 2017
Texas Children's Hospital
 
Mesa 4.4 Dr Agustín Valido
Mesa 4.4 Dr Agustín ValidoMesa 4.4 Dr Agustín Valido
Mesa 4.4 Dr Agustín Valido
FERRER EPOCSITE PRO
 
Immunotherapy for gbs
Immunotherapy for gbsImmunotherapy for gbs
Immunotherapy for gbs
Neurology resident slides
 
Pulse Wave Velocity: Theory, Applications, Methods, and Future Directions
Pulse Wave Velocity: Theory, Applications, Methods, and Future DirectionsPulse Wave Velocity: Theory, Applications, Methods, and Future Directions
Pulse Wave Velocity: Theory, Applications, Methods, and Future Directions
InsideScientific
 
ZMPCZM016000.11.08
ZMPCZM016000.11.08ZMPCZM016000.11.08
ZMPCZM016000.11.08painezeeman
 
How do we use NSAIDs with patient safety in mind
How do we use NSAIDs with patient safety in mindHow do we use NSAIDs with patient safety in mind
How do we use NSAIDs with patient safety in mind
Rachmat Gunadi Wachjudi
 
GI Bleed
GI BleedGI Bleed
12 Goldstein Pediatric Crrt Dialysis Outcome
12 Goldstein   Pediatric Crrt Dialysis Outcome12 Goldstein   Pediatric Crrt Dialysis Outcome
12 Goldstein Pediatric Crrt Dialysis OutcomeDang Thanh Tuan
 
The Role of Extracorporeal Photopheresis in Scleroderma
The Role of Extracorporeal Photopheresis in SclerodermaThe Role of Extracorporeal Photopheresis in Scleroderma
The Role of Extracorporeal Photopheresis in Scleroderma
Scleroderma Foundation of Greater Chicago
 
Comparison of Efficacy of Various Doses of Esmolol In Attenuating Presssor Re...
Comparison of Efficacy of Various Doses of Esmolol In Attenuating Presssor Re...Comparison of Efficacy of Various Doses of Esmolol In Attenuating Presssor Re...
Comparison of Efficacy of Various Doses of Esmolol In Attenuating Presssor Re...
iosrjce
 
AFFIRM trial JC NOVANT
AFFIRM trial JC NOVANTAFFIRM trial JC NOVANT
AFFIRM trial JC NOVANTElmira Darvish
 
Aidp dilemmas
Aidp dilemmasAidp dilemmas
Aidp dilemmas
DR RML DELHI
 
SALT-E 2
SALT-E 2SALT-E 2

What's hot (20)

Reduce the hospitalization
Reduce the hospitalizationReduce the hospitalization
Reduce the hospitalization
 
Journal club 20 10-2016
Journal club 20 10-2016Journal club 20 10-2016
Journal club 20 10-2016
 
Obstructive lung disease
Obstructive lung diseaseObstructive lung disease
Obstructive lung disease
 
Goal directed resuscitation for patients
Goal directed resuscitation for patientsGoal directed resuscitation for patients
Goal directed resuscitation for patients
 
Dizziness
DizzinessDizziness
Dizziness
 
Evidence Based Approach to PTE
Evidence Based Approach to PTEEvidence Based Approach to PTE
Evidence Based Approach to PTE
 
Anticoagulation in pediatric ventricular assist device - WCPCCS 2017
Anticoagulation in pediatric ventricular assist device - WCPCCS 2017Anticoagulation in pediatric ventricular assist device - WCPCCS 2017
Anticoagulation in pediatric ventricular assist device - WCPCCS 2017
 
Mesa 4.4 Dr Agustín Valido
Mesa 4.4 Dr Agustín ValidoMesa 4.4 Dr Agustín Valido
Mesa 4.4 Dr Agustín Valido
 
Immunotherapy for gbs
Immunotherapy for gbsImmunotherapy for gbs
Immunotherapy for gbs
 
Pulse Wave Velocity: Theory, Applications, Methods, and Future Directions
Pulse Wave Velocity: Theory, Applications, Methods, and Future DirectionsPulse Wave Velocity: Theory, Applications, Methods, and Future Directions
Pulse Wave Velocity: Theory, Applications, Methods, and Future Directions
 
ZMPCZM016000.11.08
ZMPCZM016000.11.08ZMPCZM016000.11.08
ZMPCZM016000.11.08
 
Telemonitoring
TelemonitoringTelemonitoring
Telemonitoring
 
How do we use NSAIDs with patient safety in mind
How do we use NSAIDs with patient safety in mindHow do we use NSAIDs with patient safety in mind
How do we use NSAIDs with patient safety in mind
 
GI Bleed
GI BleedGI Bleed
GI Bleed
 
12 Goldstein Pediatric Crrt Dialysis Outcome
12 Goldstein   Pediatric Crrt Dialysis Outcome12 Goldstein   Pediatric Crrt Dialysis Outcome
12 Goldstein Pediatric Crrt Dialysis Outcome
 
The Role of Extracorporeal Photopheresis in Scleroderma
The Role of Extracorporeal Photopheresis in SclerodermaThe Role of Extracorporeal Photopheresis in Scleroderma
The Role of Extracorporeal Photopheresis in Scleroderma
 
Comparison of Efficacy of Various Doses of Esmolol In Attenuating Presssor Re...
Comparison of Efficacy of Various Doses of Esmolol In Attenuating Presssor Re...Comparison of Efficacy of Various Doses of Esmolol In Attenuating Presssor Re...
Comparison of Efficacy of Various Doses of Esmolol In Attenuating Presssor Re...
 
AFFIRM trial JC NOVANT
AFFIRM trial JC NOVANTAFFIRM trial JC NOVANT
AFFIRM trial JC NOVANT
 
Aidp dilemmas
Aidp dilemmasAidp dilemmas
Aidp dilemmas
 
SALT-E 2
SALT-E 2SALT-E 2
SALT-E 2
 

Similar to Comparative Digital Poster

NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypert...
NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypert...NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypert...
NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypert...
Dra. Mônica Lapa
 
Progress in Pulmonary Hypertension
Progress in Pulmonary HypertensionProgress in Pulmonary Hypertension
Progress in Pulmonary Hypertension
Spectrum Health System
 
New developments in the treatment of intracerebral hemorrhage. 2013
New developments in the treatment of intracerebral hemorrhage. 2013New developments in the treatment of intracerebral hemorrhage. 2013
New developments in the treatment of intracerebral hemorrhage. 2013
Javier Pacheco Paternina
 
Effect of Allopurinol on CKD and CVD
Effect of Allopurinol on CKD and CVDEffect of Allopurinol on CKD and CVD
Effect of Allopurinol on CKD and CVDdrallam
 
PMR Buzz Magazine_April 2022.pdf
PMR Buzz Magazine_April 2022.pdfPMR Buzz Magazine_April 2022.pdf
PMR Buzz Magazine_April 2022.pdf
mrinal joshi
 
BRAINCOMS 2012 - Book of Abstracts
BRAINCOMS 2012 - Book of AbstractsBRAINCOMS 2012 - Book of Abstracts
BRAINCOMS 2012 - Book of Abstracts
slidescongresso
 
Reversing cardiac remodeling with HFtreatment
Reversing cardiac remodeling with HFtreatmentReversing cardiac remodeling with HFtreatment
Reversing cardiac remodeling with HFtreatment
Praveen Nagula
 
Power Spectral Analysis of Heart Rate Variability In Hypothyroidism
Power Spectral Analysis of Heart Rate Variability In HypothyroidismPower Spectral Analysis of Heart Rate Variability In Hypothyroidism
Power Spectral Analysis of Heart Rate Variability In Hypothyroidism
MatiaAhmed
 
PMR Buzz Magazine_Oct 2022.pdf
PMR Buzz Magazine_Oct 2022.pdfPMR Buzz Magazine_Oct 2022.pdf
PMR Buzz Magazine_Oct 2022.pdf
mrinal joshi
 
RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...
RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...
RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...
Sociedad Latinoamericana de Cardiología Intervencionista
 
Weeks_case study final
Weeks_case study finalWeeks_case study final
Weeks_case study finalAllison Weeks
 
Study review (Bosentan)
Study review (Bosentan) Study review (Bosentan)
Study review (Bosentan)
Ahmed_Yehia
 
EVALUATION OF CARDIAC AUTONOMIC REACTIVITY AMONG YOUNG HEALTHY MALE OFFSPRING...
EVALUATION OF CARDIAC AUTONOMIC REACTIVITY AMONG YOUNG HEALTHY MALE OFFSPRING...EVALUATION OF CARDIAC AUTONOMIC REACTIVITY AMONG YOUNG HEALTHY MALE OFFSPRING...
EVALUATION OF CARDIAC AUTONOMIC REACTIVITY AMONG YOUNG HEALTHY MALE OFFSPRING...
DR. SUJOY MUKHERJEE
 
Ojchd.000549
Ojchd.000549Ojchd.000549
Relation between motor recovery and level of stress in stroke survivers a cor...
Relation between motor recovery and level of stress in stroke survivers a cor...Relation between motor recovery and level of stress in stroke survivers a cor...
Relation between motor recovery and level of stress in stroke survivers a cor...Rajneesh Hbk
 
Relation between motor recovery and level of stress in stroke survivers a cor...
Relation between motor recovery and level of stress in stroke survivers a cor...Relation between motor recovery and level of stress in stroke survivers a cor...
Relation between motor recovery and level of stress in stroke survivers a cor...
Rajneesh Hbk
 
Out of hospital hypertonic saline
Out of hospital hypertonic salineOut of hospital hypertonic saline
Out of hospital hypertonic saline
nswhems
 
Hemodialysis.com | Hemodialysis | Dialysis | Kidney Disease
Hemodialysis.com | Hemodialysis | Dialysis | Kidney DiseaseHemodialysis.com | Hemodialysis | Dialysis | Kidney Disease
Hemodialysis.com | Hemodialysis | Dialysis | Kidney Disease
Marie Benz MD FAAD
 

Similar to Comparative Digital Poster (20)

NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypert...
NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypert...NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypert...
NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypert...
 
Progress in Pulmonary Hypertension
Progress in Pulmonary HypertensionProgress in Pulmonary Hypertension
Progress in Pulmonary Hypertension
 
Residency Abstract
Residency AbstractResidency Abstract
Residency Abstract
 
New developments in the treatment of intracerebral hemorrhage. 2013
New developments in the treatment of intracerebral hemorrhage. 2013New developments in the treatment of intracerebral hemorrhage. 2013
New developments in the treatment of intracerebral hemorrhage. 2013
 
Effect of Allopurinol on CKD and CVD
Effect of Allopurinol on CKD and CVDEffect of Allopurinol on CKD and CVD
Effect of Allopurinol on CKD and CVD
 
PMR Buzz Magazine_April 2022.pdf
PMR Buzz Magazine_April 2022.pdfPMR Buzz Magazine_April 2022.pdf
PMR Buzz Magazine_April 2022.pdf
 
BRAINCOMS 2012 - Book of Abstracts
BRAINCOMS 2012 - Book of AbstractsBRAINCOMS 2012 - Book of Abstracts
BRAINCOMS 2012 - Book of Abstracts
 
Reversing cardiac remodeling with HFtreatment
Reversing cardiac remodeling with HFtreatmentReversing cardiac remodeling with HFtreatment
Reversing cardiac remodeling with HFtreatment
 
Power Spectral Analysis of Heart Rate Variability In Hypothyroidism
Power Spectral Analysis of Heart Rate Variability In HypothyroidismPower Spectral Analysis of Heart Rate Variability In Hypothyroidism
Power Spectral Analysis of Heart Rate Variability In Hypothyroidism
 
PMR Buzz Magazine_Oct 2022.pdf
PMR Buzz Magazine_Oct 2022.pdfPMR Buzz Magazine_Oct 2022.pdf
PMR Buzz Magazine_Oct 2022.pdf
 
RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...
RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...
RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...
 
Weeks_case study final
Weeks_case study finalWeeks_case study final
Weeks_case study final
 
Study review (Bosentan)
Study review (Bosentan) Study review (Bosentan)
Study review (Bosentan)
 
EVALUATION OF CARDIAC AUTONOMIC REACTIVITY AMONG YOUNG HEALTHY MALE OFFSPRING...
EVALUATION OF CARDIAC AUTONOMIC REACTIVITY AMONG YOUNG HEALTHY MALE OFFSPRING...EVALUATION OF CARDIAC AUTONOMIC REACTIVITY AMONG YOUNG HEALTHY MALE OFFSPRING...
EVALUATION OF CARDIAC AUTONOMIC REACTIVITY AMONG YOUNG HEALTHY MALE OFFSPRING...
 
Ojchd.000549
Ojchd.000549Ojchd.000549
Ojchd.000549
 
Relation between motor recovery and level of stress in stroke survivers a cor...
Relation between motor recovery and level of stress in stroke survivers a cor...Relation between motor recovery and level of stress in stroke survivers a cor...
Relation between motor recovery and level of stress in stroke survivers a cor...
 
Relation between motor recovery and level of stress in stroke survivers a cor...
Relation between motor recovery and level of stress in stroke survivers a cor...Relation between motor recovery and level of stress in stroke survivers a cor...
Relation between motor recovery and level of stress in stroke survivers a cor...
 
Research article
Research articleResearch article
Research article
 
Out of hospital hypertonic saline
Out of hospital hypertonic salineOut of hospital hypertonic saline
Out of hospital hypertonic saline
 
Hemodialysis.com | Hemodialysis | Dialysis | Kidney Disease
Hemodialysis.com | Hemodialysis | Dialysis | Kidney DiseaseHemodialysis.com | Hemodialysis | Dialysis | Kidney Disease
Hemodialysis.com | Hemodialysis | Dialysis | Kidney Disease
 

Comparative Digital Poster

  • 1. Flow-regulated vs Pressure-regulated shunts: A Prospective Analysis in Patients with Idiopathic Normal Pressure Hydrocephalus Phillip G. St. Louis MD; Jennifer Clements Associates in Neurosurgery Introduction Guidelines for treatment of Idiopathic Normal Pressure (INPH)indicate ventriculoperitoneal shunt placement as an effective intervention. Current literature comparing Differential Pressure (DP) versus Flow Regulated (FR) Valves for is lacking. This prospective study evaluates one year outcome data of 43 patients randomized to either a DP or FR valve. Methods All patients completed pre-operative and post-operative evaluations to assess hallmark indicators of INPH such as magnetic gait (BERG Balance Scale), cognitive dysfunction (Neuropsychological Assessment Battery [NAB]), and ventriculomegaly (MRI/CT). Patients who consented were then randomized to a DP or FR valve. Results Baseline testing of the DP Group (N=22) was NAB: 78.16 and BERG 34.2. Significant improvement was demonstrated at 6 and 12 months post-operatively with NAB: 86.5 and 87.75, and BERG 43.06,44.17 scores. Baseline testing for the FR Group (N=21) was NAB: 77.4 and BERG: 39. Improvement was noted at 6 and 12 months post operatively with NAB: 86.25 and 89.17. There was a slight decrease in the 6 and 12 month BERG: 47.2 and 46.11 scores. There were no shunt infections. There was one subdural hematoma in the FR Group requiring surgical intervention in the immediate post-operative period, and 3 subdural hematomas in the DP Group requiring 1 surgical intervention. The number of follow up appointments was slightly increased in the DP Group, which was primarily related to patients who required shunt reprogramming. Conclusions Both shunt systems appear to be effective in treatment of INPH. Improvement was noted in both NAB and BERG at 6 and 12 months post- operatively when compared to baseline. There was a distinct trend of more striking improvement at 6 months in the FR Group. A significantly higher incidence of subdural hematomas was demonstrated in the DP Group, most of which were successfully managed by shunt reprogramming. Learning Objectives Patients with Flow Regulated Valves demonstrated a more striking improvement at 6 months. Patients with Differential Pressure Valves experienced a larger incidence of subdural hematomas, however most of which were managed by shunt reprogramming. Both groups demonstrated overall improvement when compared to baseline References 1.Gangemi M, Maiuri F, Naddeo M, Godano U, Mascari C, Broggi, et al: Endoscopic Third Ventriculostomy in Idiopathic Normal Pressure Hydrocephalus: An Italian Multicenter Study. Neurosurg, 63: 62-69, 2008. 2.Hanlow P, Cinalli G, Vandertop P, Faber J, Bogeskov L, Borgesen S, et al: Treatment of hydrocephalus determined by the European Orbis Sigma Valve II survey: a multicenter prospective 5-year shunt survival study in children and adults whom a flow-regulating shunt was used. J Neurosurg 99: 52-57, 2003.3.Philippe D, Barat J, Duplessis E, Leguerinel C, Gendrault P, and Keravel Y: Shunt failure in adult hydrocephalus: Flow-controlled shunt versus differential pressure shunts- A cooperative study in 289 patients. Surg Neurol 43:333-339, 1995.4.Weiner H, Shlomo C, Cohen H, Wisoff J: Current Treatment of Normal -pressure Hydrocephalus: Comparison of Flow- regulated and Differential-pressure Shunt Valves. Neurosurg, 37(5):877-884, 1995.5.Zemack G, and Romner B: Adjustable Valves in normal-pressure hydrocephalus: A retrospective study of 218 patients. Neurosurg 51:1392-1402, 2002.6.Knutsson E, Lying-Tunell U. Gait apraxia in normal-pressure hydrocephalus: Patterns of movement and muscle activation. Neurology 35, 135- 160.7.Bugalho P, Guimaraes J. Gait disturbance in normal pressure hydrocephalus: A clinical study. Parkinsonism and Related Disorders 13, 434-437, 2007.8.St Louis P, Horn G, Gorman P, Johnson-Markve B, Wong B, Brustch B, Baez- Torres S, Cole A, Tuppeny M, Johnson R. Neurotransmission. 4, 1 2012. 9.Ravdin et al. Features most responsive to tap test in normal pressure hydrocephalus. Clin Neurol Neurosurg.2008 May; 110 (5): 455-461.10. Shprecher D, Schwalb J, Kurlan R. Normal Pressure Hydrocephalus: Diagnosis and Treatment. Curr Neurol Neurosci Rep. 2008 September; 8(5): 371-376.11.Merten T. Neuropsychology of Normal Pressure Hydrocephalus [in German]. Nervenarzt 70:496 -503, 1999. 12. Relkin N, Marmarou A, Klinge P, Bergsneider M, Black P. Diagnosing Idiopathic Normal-Pressure Hydrocephalus. Neurosurgery. 57:3, 2005. 13. Vaneste JA. Diagnosis and management of normal pressure hydrocephalus. J Neurol. 2000;247:5-14. 14. Donoghue D; Physiotherapy Research and Older People (PROP) group, Stokes EK. (2009). How much change is true change? The minimum detectable change of the Berg Balance Scale in elderly people. J Rehabil Med. 41(5):343-6. 15 Stern, R. A. & White T. (2003). Neuropsychological Assessment Battery: Administration, Scoring, and Interpretation Manual,Psychological Assessment Resources, Inc., Lutz, FL.16.Duff K. Evidence-based indicators of neuropsychological change in the individual patient: Relevant concepts and methods; Kevin Duff; archives of clinical neuropsychology; May 2012; 27(3): 248-261. BERG Balance Scale NAB
  • 3. NAB